Equillium (EQ) Cash from Investing Activities (QoQ) (2018 - 2026)
Equillium (EQ) Cash from Investing Activities (QoQ) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Equillium |
293.17 Mn |
232.78 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
90.63% |
| Mar 31, 2025 |
-25.02% |
| Dec 31, 2024 |
-50.03% |
| Sep 30, 2024 |
988.23% |
| Jun 30, 2024 |
52.28% |
| Mar 31, 2024 |
49.14% |
| Dec 31, 2023 |
-150.67% |
| Sep 30, 2023 |
-26.77% |
| Jun 30, 2023 |
159.57% |
| Mar 31, 2023 |
-460.86% |
| Dec 31, 2022 |
-53.48% |
| Sep 30, 2022 |
72.59% |
| Jun 30, 2022 |
172.52% |
| Mar 31, 2022 |
29.04% |
| Dec 31, 2021 |
-261.34% |
| Sep 30, 2021 |
-63.86% |
| Jun 30, 2021 |
496.03% |
| Mar 31, 2021 |
128.53% |
| Dec 31, 2020 |
25.98% |
| Sep 30, 2020 |
-372.22% |
